Sumitomo Pharma Co Ltd
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 4506-T would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2000) — listing | $70,191 1.8× | $102,622 1.8× |
| Year 6 (2005) | $53,882 1.7× | $79,718 1.7× |
| Year 11 (2010) | $38,851 1.6× | $57,750 1.6× |
| Year 16 (2015) | $24,383 1.4× | $36,189 1.5× |
| Year 21 (2020) | $16,870 1.8× | $25,164 1.8× |
| Year 26 (2025) | $2,761 1.4× | $4,160 1.4× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 4506
For illustration only — not investment advice. Past performance is not indicative of future results.